Incorrect username and/or password, please try again or click to reset.

Class 2 Medicines Recall: Co-amoxiclav 125 mg/31.25 mg/5 ml and 25 mg/62.5 mg/5 ml Powder for Oral Suspension (MDR 24-05/19)

2019-05-13 11:01:23 (4 month(s) ago)

Summary

Sandoz Ltd. have been notified of a potential packaging problem relating to poor seal adherence which could cause clumping of the powder within the bottle.

Read full MHRA article

Respond to this alert